Computational design and validation of siRNA molecules to silence oncogenic CTNNB1 mRNA as a potential therapeutic strategy against hepatitis B/C virus-associated hepatocellular carcinoma
The majority of hepatocellular carcinoma cases are caused by infection with hepatitis B (HBV) or C (HCV) viruses. CTNNB1 is the most mutated oncogene in HBV- and HCV-associated tumors. CTNNB1 mutations can lead to β-catenin accumulation, resulting in tumor progression. Small interfering RNAs (siRNAs...
Saved in:
Main Authors: | Lauren Emily Fajardo (Author), Mark Andrian Macalalad (Author), Nyzar Mabeth Odchimar (Author), John Christian de Guzman (Author), Fredmoore Orosco (Author) |
---|---|
Format: | Book |
Published: |
Pensoft Publishers,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intratracheal Administration of siRNA Triggers mRNA Silencing in the Lung to Modulate T Cell Immune Response and Lung Inflammation
by: Bruce Ng, et al.
Published: (2019) -
siRNA Versus miRNA as Therapeutics for Gene Silencing
by: Jenny K W Lam, et al.
Published: (2015) -
Hydrophobically Modified siRNAs Silence Huntingtin mRNA in Primary Neurons and Mouse Brain
by: Julia F Alterman, et al.
Published: (2015) -
The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma
by: Ling Yang, et al.
Published: (2013) -
Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference
by: Chantal M. Ferguson, et al.
Published: (2020)